Inappropriate antibiotic administration in the setting of Charcot arthropathy: A case series and literature review.
Charcot foot
Charcot neuropathic osteoarthropathy
Delayed treatment
Diabetes
Diabetes mellitus
Inappropriate treatment
Journal
Primary care diabetes
ISSN: 1878-0210
Titre abrégé: Prim Care Diabetes
Pays: England
ID NLM: 101463825
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
22
06
2021
revised:
15
11
2021
accepted:
28
11
2021
pubmed:
12
12
2021
medline:
22
3
2022
entrez:
11
12
2021
Statut:
ppublish
Résumé
Differentiating Charcot neuropathic osteoarthropathy (CN) from infection is challenging. The diagnosis of CN is often missed or delayed, resulting in inappropriate and delayed treatment. We hypothesized that the misdiagnosis of CN results in inappropriate antibiotic prescriptions and explore the sequelae of unnecessary antibiotic use. A retrospective review of patient electronic medical records from January 2010 to December 2017 was conducted for those diagnosed with CN after being referred to an orthopaedic foot and ankle specialist. Our review showed 58 of 103 (56%) patients received antibiotics on the date, or within the next 7 days, of referral to foot and ankle orthopaedic specialist. The antibiotic of choice given on referral were as follows: Sulfamethoxazole/Trimethoprim 18 of 58 (31%), doxycycline 13 of 58 (22%), clindamycin 13 of 58 (22%), cephalexin 9 of 58 (16%), minocycline 5 of 58 (9%). Missed diagnoses for CN are common and result in complications stemming from inappropriate treatment, delays in appropriate therapy, and may accelerate antibiotic resistance. Misdiagnosis of CN contributes to the inappropriate use of prescription antibiotics.
Identifiants
pubmed: 34893452
pii: S1751-9918(21)00216-3
doi: 10.1016/j.pcd.2021.11.009
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
202-206Informations de copyright
Copyright © 2021 Primary Care Diabetes Europe. All rights reserved.